Preview

Health and Ecology Issues

Advanced search

THE BRAFT1796A TRANSVERSION IS A PREVALENT MUTATIONAL EVENT IN HUMAN THYROID MICROCARCINOMA

https://doi.org/10.51523/2708-6011.2006-3-1-5

Abstract

The results show that BRAFT1799A mutation is a prevalent event in human thyroid microcarcinomas irrespectively of the genetic background of adult patients. Mutated BRAF might be involved in the control of tumors architecture and growth pattern but its presence does not correlate with manifestations of papillary microcarcinomas (PMC) aggressiveness. Whereas BRAF mutation comprise a common genetic alteration in conventional papillary thyroid carcinoma (PTC) and PMC, a number of differences in mutation-related associations between the two types of tumors rather supports the hypothesis that not all macroscopic PTCs may arise from papillary microcarcinoma.

About the Authors

I. . Sedliarou
Departments of Molecular Medicine, International Health and Radiation Research, Tissue and Histopathology Section, Department of Biomedical Statistics, Atomic Bomb Disease Institute, Nagasaki University Graduate
Belarus


V. . Saenko
School of Biomedical Sciences Clinical-Morphological Department, Medical Radiological Research Center RAMS
Belarus


T. . Rogounovitch
School of Biomedical Sciences Clinical-Morphological Department, Medical Radiological Research Center RAMS
Belarus


H. . Namba
School of Biomedical Sciences Clinical-Morphological Department, Medical Radiological Research Center RAMS
Belarus


A. . Abrosimov
School of Biomedical Sciences Clinical-Morphological Department, Medical Radiological Research Center RAMS
Belarus


E. . Lushnikov
School of Biomedical Sciences Clinical-Morphological Department, Medical Radiological Research Center RAMS
Belarus


M. . Matsuse
Department of Pathology, Nagasaki University Hospital
Belarus


A. . Kumagai
Department of Pathology, Nagasaki University Hospital
Belarus


M. . Nakashima
Department of Pathology, Nagasaki University Hospital
Belarus


S. . Meirmanov
Department of Pathology, Nagasaki University Hospital
Belarus


T. . Hayashi
Department of Pathology, Nagasaki University Hospital
Belarus


M. . Mine
Department of Pathology, Nagasaki University Hospital
Belarus


S. . Yamashita
Department of Pathology, Nagasaki University Hospital
Belarus


References

1. Franceschi S., Boyle P., Maisonneuve P., La Vecchia C., Burt A.D., Kerr D.J. and MacFarlane G.J. The epidemiology of thyroid carcinoma // Crit Rev Oncog. - 1993. - Vol. 4. - P. 25-52.

2. Fink A., Tomlinson G., Freeman J.L., Rosen I.B. and Asa S.L. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms // Mod Pathol. - 1996. - Vol. 9. - Р. 816-820.

3. Yamashita H., Noguchi S., Murakami N., Toda M., Uchino S., Watanabe S. and Kawamoto H. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinomaь // Cancer. - 1999. - Vol. 86. - Р. 842-849.

4. Mercer K.E. and Pritchard C.A. Raf proteins and cancer: B-Raf is identified as a mutational target // Biochim Biophys Acta. - 2003. - Vol. 1653. - Р. 25-40.

5. Kimura E.T., Nikiforova M.N., Zhu Z., Knauf J.A., Nikiforov Y.E. and Fagin J.A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma // Cancer Res. - 2003. - Vol. 63. - Р. 1454-1457.

6. Xu X., Quiros R.M., Gattuso P., Ain K.B. and Prinz R.A. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines // Cancer Res. - 2003. - Vol. 63. - Р. 4561-4567.


Review

For citations:


Sedliarou I., Saenko V., Rogounovitch T., Namba H., Abrosimov A., Lushnikov E., Matsuse M., Kumagai A., Nakashima M., Meirmanov S., Hayashi T., Mine M., Yamashita S. THE BRAFT1796A TRANSVERSION IS A PREVALENT MUTATIONAL EVENT IN HUMAN THYROID MICROCARCINOMA. Health and Ecology Issues. 2006;(1):31-34. (In Russ.) https://doi.org/10.51523/2708-6011.2006-3-1-5

Views: 256


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2220-0967 (Print)
ISSN 2708-6011 (Online)